Skip to main content
Vistin Pharma logo

Vistin Pharma — Investor Relations & Filings

Ticker · VISTN ISIN · NO0010734122 LEI · 5967007LIEEXZXFQY092 OL Manufacturing
Open in API
Filings indexed 519 across all filing types
Latest filing 2025-05-22 AGM Information
Country NO Norway
Listing OL VISTN

About Vistin Pharma

https://www.vistin.com/

Vistin Pharma is a pharmaceutical company specializing in the production of Metformin Hydrochloride, an Active Pharmaceutical Ingredient (API). The company operates as a pure-play, global supplier, providing high-quality Metformin to pharmaceutical companies worldwide. In addition to the standard API, Vistin Pharma offers specialized grades such as Direct Compressible (DC) Metformin. With over 50 years of experience, the company emphasizes sustainable manufacturing from its dedicated European production facility.

Recent filings

Filing Released Lang Actions
Vistin Pharma ASA: Minutes from the annual general meeting 2025
AGM Information Classification · 98% confidence The document title explicitly states 'Minutes from the annual general meeting 2025'. The text confirms that the minutes from the AGM held on May 22, 2025, are attached. Since this document is very short (568 characters) and serves to announce the availability of the minutes rather than being the full minutes document itself, it fits the description of an announcement related to the AGM. However, the closest specific category for materials shared during the AGM is 'AGM Information' (AGM-R). Given the context of providing the minutes, AGM-R is the most appropriate classification, as the minutes are a core component of the AGM documentation.
2025-05-22 English
Disclosure of voting rights at AGM in Vistin Pharma ASA
Proxy Solicitation & Information Statement Classification · 99% confidence The document explicitly discusses the 'Disclosure of voting rights at AGM' and details the number of shares represented by proxies and held by the Chair of the Board for the Annual General Meeting (AGM) held on May 22, 2025. This content directly relates to the voting structure and results/representation at a general meeting. This aligns perfectly with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes at any general meeting.
2025-05-22 English
Vistin Pharma ASA (VISTN): Update from the Election Committee
Board/Management Information Classification · 98% confidence The document is a short announcement from the Election Committee of Vistin Pharma ASA regarding a change in board member nominations for the upcoming annual general meeting (AGM). Specifically, it states that a current board member, Øystein Stray Spetalen, does not wish to be re-elected, and the committee has decided not to propose a replacement, resulting in a reduction of one board member. This directly concerns the composition of the board of directors and senior management, which aligns with the definition for Board/Management Information (MANG). It is not a full AGM presentation (AGM-R), a formal voting result (DVA), or a general regulatory filing (RNS), but a specific update on board composition.
2025-05-07 English
Vistin Pharma ASA (VISTN): Mandatory notification of trade and disclosure of large shareholding
Director's Dealing Classification · 100% confidence The document is a standardized template titled "Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them." It details a 'Sale of shares' transaction involving an executive's closely associated person (Øystein Stray Spetalen) in Vistin Pharma ASA. This structure precisely matches the definition of Director's Dealing, which reports personal share transactions by company directors and executives (insider trades). The corresponding code is DIRS.
2025-05-06 English
Vistin Pharma ASA (VISTN): Mandatory notification of trade and disclosure of large shareholding
Director's Dealing Classification · 100% confidence The document is a structured notification template titled "Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them." It details a 'Sale of shares' transaction involving a person closely associated with a board member of Vistin Pharma ASA. This specific reporting requirement for insider transactions (transactions by directors or closely associated persons) directly corresponds to the definition of Director's Dealing. Therefore, the appropriate filing code is DIRS.
2025-05-06 English
Vistin Pharma ASA (VISTN): Mandatory notification of trade and disclosure of large shareholding
Director's Dealing Classification · 100% confidence The document is a structured template titled "Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them." It details a 'Purchase of shares' transaction involving a person closely associated with the Chairman of Vistin Pharma ASA. This content directly corresponds to the reporting requirements for insider trading or director/executive share transactions. Based on the provided definitions, this aligns perfectly with the Director's Dealing category (DIRS).
2025-05-06 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.